MX2016007202A - Uso de monooxigenasa alfa-amidante de peptidilglicina (pam) para amidacion c-terminal. - Google Patents

Uso de monooxigenasa alfa-amidante de peptidilglicina (pam) para amidacion c-terminal.

Info

Publication number
MX2016007202A
MX2016007202A MX2016007202A MX2016007202A MX2016007202A MX 2016007202 A MX2016007202 A MX 2016007202A MX 2016007202 A MX2016007202 A MX 2016007202A MX 2016007202 A MX2016007202 A MX 2016007202A MX 2016007202 A MX2016007202 A MX 2016007202A
Authority
MX
Mexico
Prior art keywords
pam
terminal amidation
peptidylglycine alpha
monooxigenase
amidating
Prior art date
Application number
MX2016007202A
Other languages
English (en)
Inventor
Georg Tiefenthaler
Eike Hoffmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2016007202A publication Critical patent/MX2016007202A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/17—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced ascorbate as one donor, and incorporation of one atom of oxygen (1.14.17)
    • C12Y114/17003—Peptidylglycine monooxygenase (1.14.17.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y403/00—Carbon-nitrogen lyases (4.3)
    • C12Y403/02—Amidine-lyases (4.3.2)
    • C12Y403/02005—Peptidylamidoglycolate lyase (4.3.2.5)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un aspecto que se reporta en la presente es un método para la amidación C-terminal in vivo de un polipéptido se caracteriza en que tanto el polipéptido (se amidará) y la monooxigenasa alfa-amidante de peptidilglicina (PAM) de humano se expresa complementaria y recombinantemente en una célula de mamífero.
MX2016007202A 2013-12-20 2014-12-10 Uso de monooxigenasa alfa-amidante de peptidilglicina (pam) para amidacion c-terminal. MX2016007202A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13199222 2013-12-20
PCT/EP2014/077143 WO2015091131A1 (en) 2013-12-20 2014-12-10 Use of peptidylglycine alpha-amidating monooxigenase (pam) for c-terminal amidation

Publications (1)

Publication Number Publication Date
MX2016007202A true MX2016007202A (es) 2016-07-21

Family

ID=49885043

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016007202A MX2016007202A (es) 2013-12-20 2014-12-10 Uso de monooxigenasa alfa-amidante de peptidilglicina (pam) para amidacion c-terminal.

Country Status (10)

Country Link
US (1) US20160333386A1 (es)
EP (1) EP3083662A1 (es)
JP (1) JP2017507645A (es)
KR (1) KR20160098278A (es)
CN (1) CN105793278A (es)
BR (1) BR112016012325A2 (es)
CA (1) CA2928927A1 (es)
MX (1) MX2016007202A (es)
RU (1) RU2016129516A (es)
WO (1) WO2015091131A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115243709A (zh) * 2020-02-26 2022-10-25 Pam治疗诊断有限公司 肽酰甘氨酸α-酰胺化单加氧酶(PAM)用于治疗目的的用途
US20230097988A1 (en) * 2020-02-26 2023-03-30 Pam Theragnostics Gmbh Methods for determining peptidylglycine alpha-amidating monooxygenase (pam) and its use for diagnostic purpose
WO2025133225A1 (en) * 2023-12-22 2025-06-26 Pam Theragnostics Gmbh Pharmaceutical combination of peptide-gly and peptidylglycine alpha-amidating monooxygenase (pam)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8660701A1 (es) * 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
US8008453B2 (en) * 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
US9096843B2 (en) * 2009-12-01 2015-08-04 Novo Nordisk A/S Peptidyl α-hydroxyglycine α-amidating lyases

Also Published As

Publication number Publication date
US20160333386A1 (en) 2016-11-17
RU2016129516A (ru) 2018-01-25
CA2928927A1 (en) 2015-06-25
EP3083662A1 (en) 2016-10-26
CN105793278A (zh) 2016-07-20
KR20160098278A (ko) 2016-08-18
WO2015091131A1 (en) 2015-06-25
JP2017507645A (ja) 2017-03-23
BR112016012325A2 (pt) 2017-09-26

Similar Documents

Publication Publication Date Title
UA115120C2 (uk) Спосіб застосування химерного поліпептиду фактора ix
NZ711445A (en) Fusion immunomodulatory proteins and methods for making same
MY162837A (en) Modified relaxin polypeptides and their uses
IN2014DN06200A (es)
CR20140586A (es) Celulas para producir iduronato-2-sulfatasa recombinante
IN2014MN01970A (es)
PH12014502537A1 (en) Therapeutic uses of fibroblast growth factor 21 proteins
NZ603196A (en) Methods of use of soluble cd24 for therapy of rheumatoid arthritis
SG11201601262QA (en) CELL CULTURE MEDIUM AND PROCESS FOR CONTROLLING α-AMIDATION AND/OR C-TERMINAL AMINO ACID CLEAVAGE OF POLYPEPTIDES
MX336489B (es) Hormona foliculo estimulante humana recombinante composicion farmaceutica que la comprende y uso de la misma.
MX2016000393A (es) Modificaciones de proteinas quimioenzimaticas de lisina utilizando transglutaminasa microbiana.
MX2014014464A (es) Peptidos penetrantes de celulas y metodos para identificar peptidos penetrantes de celulas.
EA201290541A1 (ru) Модифицированные бычьи соматотропиновые полипептиды и их применение
MX2020012356A (es) Sobreexpresion de reguladores de la ruta de n-glicosilacion para modular la glicosilacion de proteinas recombinantes.
EA201290542A1 (ru) Модифицированные свиные соматотропиновые полипептиды и их применение
MX354156B (es) Dipeptido que comprende un aminoacido no proteogenico.
NZ594198A (en) Neil3 peptides and vaccines including the same
MX381841B (es) Anticuerpos anti-jagged y métodos de uso.
AU329039S (en) Maternity shorts
IN2015DN02873A (es)
AU340528S (en) Insole
IL289372A (en) A process for recycling organic matter to produce methane and/or hydrogen
IN2013MU02527A (es)
SG11201600872UA (en) Means and methods for the generation of mammalian producer cells for the production of recombinant proteins
BR112016012325A2 (pt) métodos para amidação c-terminal in vivo de um polipeptídeo e para a produção recombinante de um polipeptídeo e uso de uma peptidilglicina